Tarrytown, NY, United States of America

Juan Rodriguez-Flores

This inventor holds 1 USPTO granted patent. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Juan Rodriguez-Flores. Retrieved from https://idiyas.com/inventor/juan-rodriguez-flores

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Juan Rodriguez-Flores: Innovator in Cerebrovascular Disease Treatment

Introduction

Juan Rodriguez-Flores is a notable inventor based in Tarrytown, NY (US). He has made significant contributions to the field of medicine, particularly in the treatment of cerebrovascular diseases. His innovative work has led to the development of a patent that addresses critical health issues.

Latest Patents

Juan holds a patent for the "Treatment Of Cerebrovascular Disease With Neurogenic Locus Notch Homolog Protein 3 (NOTCH3) Agents." This patent represents a significant advancement in therapeutic options for patients suffering from cerebrovascular conditions. His work in this area showcases his commitment to improving health outcomes through innovative solutions.

Career Highlights

Juan Rodriguez-Flores is currently employed at Regeneron Pharmaceuticals, Inc., where he continues to push the boundaries of medical research and innovation. His role at Regeneron allows him to collaborate with leading experts in the field and contribute to groundbreaking projects that aim to enhance patient care.

Collaborations

One of his notable collaborators is Alan Shuldiner, with whom he has worked closely on various projects. Their partnership exemplifies the importance of teamwork in the pursuit of scientific advancements.

Conclusion

Juan Rodriguez-Flores is a dedicated inventor whose work in cerebrovascular disease treatment is making a difference in the medical field. His innovative approach and commitment to research continue to inspire advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…